Polymorphisms in ERCC genes are considered significant risk factors in various analyses (21–24), including those related to NSCLC (25–29), and the expression of ERCC6L is increased in tumor samples of various cancer types, including lung cancers (30, 31). Here, ERCC6L is linked to neoplasm.